Press Releases

EndoBarrier® Therapy Receives OPS Codes in Germany and Switzerland

LEXINGTON, Massachusetts & SYDNEY, Australia – 1 October 2013 – GI Dynamics, Inc. (ASX: GID) announced today that the German Institute of Medical Documentation and Information (DMDI) has designated preliminary OPS codes (Operationen- and Prozedurenschlussel) to EndoBarrier® Therapy which is...

read more

GI Dynamics, Inc. Provides Update on Progress of the ENDO Trial

LEXINGTON, Massachusetts & SYDNEY – 12 September 2013 – GI Dynamics, Inc. (ASX: GID) today announced an update on the progress of the ENDO Trial, its U.S. multi-center, pivotal clinical trial of EndoBarrier® for the treatment of patients who have uncontrolled type 2 diabetes and obesity. To...

read more
Page 1 of 3123